eFFECTOR Therapeutics, Inc. ( EFTR) - Key Metrics
EFTR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q1 | $0 | -$3.31 | -$2.73 | -$2.73 |
| 2023Q4 | $0.06 | -$3.42 | -$2.08 | -$2.10 |
| 2023Q3 | $0 | -$3.36 | -$3.14 | -$3.14 |
| 2023Q2 | $0 | -$4.37 | -$4.49 | -$4.51 |
| 2023Q1 | $0 | -$5.96 | -$4.55 | -$4.55 |
EFTR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q1 | 0% | -1.18 |
| 2023Q4 | 0% | -0.85 |
| 2023Q3 | 0% | -1.12 |
| 2023Q2 | 0% | -1.19 |
| 2023Q1 | 0% | -0.37 |
EFTR
Price: $0
52 week price:
Earnings Per Share: -12.57 USD
P/E Ratio: -0.65
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 547000
Market Capitalization: 941